The following article relates to the Pfizer COVID Vaccine Protocol#C4591001: All participants who courageously volunteered to help make a difference during this pandemic have the option to receive the investigational vaccine while continuing to be part of the clinical trial. The Vaccine Transition Option The Vaccine Transition Option is a voluntary process that offers all participants 16 years and older … Read More
How the Tuskegee Experiments Changed Clinical Trials
In 1932, 600 African American men from Macon County, Alabama were told they were receiving treatment for bad blood. Unbeknownst to them, they were enlisted in what became a tragic 40-year study to observe untreated syphilis in black populations. Withholding not only their diagnosis but also treatment cost the lives of some of these men and drastically impacted their families. … Read More
What Does It Take To Launch A Vaccine Trial
Dr. Macaya Douoguih of Janssen pharmaceuticals explains what it takes to launch a vaccine trial.
Staff Member Spotlight: Breanna Grijalva, PRI
This interview is the second part in an ongoing series featuring our amazing clinical staff members — sharing with you the work they do for Wake Research’s site network, and why they chose a career in clinical research. Breanna Grijalva, Patient Recruiter, Pharmacology Research Institute What is your role at Wake Research? I am a patient recruiter. My job … Read More
Clinical Trials: Diverse Groups Of Participants Are Needed Now More Than Ever
Why Clinical Trials are Safe Prior to new medicines being mass-produced and available to doctors to prescribe, clinical trials must be conducted in order to evaluate the safety and effectiveness of that medicine. Data from these clinical trials are required as a condition of approval by regulatory authorities such as the U.S Food and Drug Administration (FDA). Clinical Trials in … Read More
Staff Member Spotlight: Barbara Wheeler, Wake Research Raleigh
This interview is the first part in an ongoing series featuring our amazing clinical staff members — sharing with you the work they do for Wake Research’s site network, and why they chose a career in clinical research. Barbara (BJ) Wheeler, Senior Clinical Coordinator, Wake Research What is your role at Wake Research? I am a senior Clinical Coordinator at … Read More
Wake Research Begins Recruiting Healthy Adults for COVID-19 Vaccine Clinical Trial
Raleigh, NC; August 7, 2020 – Wake Research announced today it has begun recruiting healthy adults for a Phase 3 clinical research study to evaluate the safety and effectiveness of mRNA-1273, a vaccine candidate against COVID-19. Sponsored by Moderna, the COVE Study is recruiting healthy volunteers ages 18 or older in high-risk populations, including the elderly, racial and ethnic minorities … Read More
Dr. Grach Featured In Triangle Business Journal
The CEO of Wake Research, Dr. Ella Grach, was interviewed by Triangle Business Journal. You can read the full interview here. A Triangle-based clinical organization plans to begin administering a Covid-19 vaccine candidate to patients in Raleigh in early July as part of clinical trials associated with the drug. For information on COVID-19 clinical trials please visit our COVID studies … Read More
Wake Research and EmergeOrtho Teaming Up For Back Pain Studies
Back pain is an extremely common affliction, touching many people every day. It affects mostly adults, but back pain can occur at any age. Orthopedic research studies have found that 10 to 15 percent of adults will experience prevalent back pain in their lives,[1] and across the world, back pain is the number one cause of disability, causing adults to … Read More
Wake Research To Provide COVID-19 Clinical Trials Nationwide
Wake research provides investigational health services to COVID patients nationwide via the newest clinical research trials Seven Sites Now Enrolling for COVID-19 Vaccine Trials, Testing, Inpatient and Outpatient COVID Treatment Studies (Raleigh, NC) June 10, 2020– Wake Research, a national leader in clinical research and one of the largest Phase I-IV clinical trial service companies in North America, announces the … Read More